Barbara Fetterman - Concepedia

Author

Barbara Fetterman

Kaiser Permanente ORCID

Also Known As

B FETTERMAN, B. Fetterman, Barbara Fetterman, Barbara J Fetterman, Barbara J. Fetterman, Fetterman, Barbara

104

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Kaiser Permanente National Cancer Institute Albert Einstein College of Medicine National Institutes of Health Information Management Services

About

Barbara Fetterman is an author at Kaiser Permanente specializing in medicine, public health, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.4K
2	Public Health	12	12	1.4K
3	Obstetrics	11	11	1.4K
4	Epidemiology	7	7	1K
5	Cell Biology	1	1	170

Barbara Fetterman

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Identifying Women With Cervical Neoplasia M. Michele Manos, Walter Kinney, Leo B. Hurley, JAMA	1999	583
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Hormuzd A. Katki, Walter Kinney, Barbara Fetterman, The Lancet Oncology Cervical CytologyPrecancerous LesionsGynecologyGynecology OncologyCancer-associated Virus	2011	563
Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test Julia C. Gage, Mark Schiffman, Hormuzd A. Katki, JNCI Journal of the National Cancer Institute Epidemiology Of CancerPathologyGynecologyPrimary HpvCervical Cancer Prevention	2014	261
Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines Hormuzd A. Katki, Mark Schiffman, Philip E. Castle, Journal of Lower Genital Tract Disease	2013	201
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women Nicolas Wentzensen, Barbara Fetterman, Philip E. Castle, JNCI Journal of the National Cancer Institute	2015	173
Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detection Brigitte M. Ronnett, M. Michele Manos, Janice E. Ransley, Human Pathology Atypical Glandular CellsDiagnosisPathologyGynecologyCytopathology	1999	170
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening Mark Schiffman, Walter Kinney, Li C. Cheung, JNCI Journal of the National Cancer Institute	2017	159
Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting Philip E. Castle, Barbara Fetterman, Nancy Poitras, Obstetrics and Gynecology	2009	111
Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women Megan A. Clarke, Ana Gradíssimo, Mark Schiffman, Clinical Cancer Research	2018	111
Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results Hormuzd A. Katki, Mark Schiffman, Philip E. Castle, Journal of Lower Genital Tract Disease	2013	110

Page 1